Levonille

Ethinylestradiol and Levonorgestrel, the active ingredient in Levonille, is a combined oral contraceptive presented as a tablet for oral use. It works by suppressing ovulation and altering cervical mucus to prevent pregnancy in women of reproductive age.

GNH USA supplies Levonille as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is manufactured under strict quality controls.

Levonille, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

- Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Menstrual cycle regulation: helps achieve more predictable menstrual bleeding patterns. - Reduction of functional ovarian cysts: decreases the incidence of ovarian cyst formation.

Levonille may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional mild to moderate pain. - Spotting or breakthrough bleeding: irregular light bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke or myocardial infarction: rare cardiovascular events. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hepatic adenoma: benign liver tumor. - Vision changes: sudden visual disturbances.

Before prescribing Levonille, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Assess thrombotic risk: review personal and family history of clotting disorders. - Evaluate cardiovascular health: consider hypertension, smoking status, and age. - Screen for hormone‑sensitive cancers: avoid in active breast or endometrial cancer. - Review liver function: contraindicated in severe hepatic impairment. - Counsel on smoking: advise cessation, especially for women over 35. - Store below 25°C: keep in the original pack, protect from moisture.

Levonille can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin or rifabutin: decrease hormone levels, increasing risk of pregnancy. - Protease inhibitors (e.g., ritonavir): may cause unpredictable hormone concentrations. - St. John’s wort: herbal inducer that lowers contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): possible reduced absorption. - Antifungal agents (e.g., ketoconazole, itraconazole): may increase hormone levels, raising side‑effect risk. - Diuretics (e.g., thiazides): can affect fluid balance and blood pressure.